Artificial wombs that serve as surrogate mothers enable the growth of the baby from conception to birth outside the mother’s body. Amidst increasing infertility rates among women, artificial wombs are likely to gain huge demand worldwide. Further, artificial wombs can play a major role in saving prematurely born infants. In addition, they can avoid miscarriages and protect babies from a wide range of conditions.
The artificial womb market is estimated at $XX million in 2023, owing to its use as a replacement for an incubator and artificial respiration. The healthcare settings offering artificial wombs offer oxygen and nutrients through an umbilical cord using an artificial placenta. Strong growth in investments from companies, research institutes, government programs, and others presents strong growth prospects for artificial wombs. From 2023 to 2030, we estimate the global artificial womb market to register XX% market growth to reach $XX billion by end of the decade.
Market Drivers- Pregnancy Complications and mortality rates support the adoption of the artificial womb
In addition to infertility issues, increasing complications in pregnancy, high mortality rates, and others are driving the demand for artificial wombs. According to the WHO, every day in 2017, approximately 810 women died from pregnancy and childbirth, owing to severe bleeding, infection, pre-eclampsia, and other conditions. In addition to increasing awareness, and drive towards family planning, the growing median age of first-time pregnancies presents the market potential for artificial wombs.
Further, every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation). A significant portion of these preterm babies faces disabilities. Accordingly, the demand for developing an efficient and safe artificial womb is widely observed.
EctoLife Artificial Womb Facility, which can incubate up to 30,000 babies a year was announced in December 2022. The company markets artificial wombs as safe and pain-free alternatives.
€2.9 million grant from the EU program Horizon 2020 for a consortium that will be led by researchers from Eindhoven. Professors Frans van de Vosse (Biomedical Engineering), Loe Feijs (Industrial Desing), and Guid Oei (Electrical Engineering and Máxima Medical Center)
In August 2022, Vitara Biomedical raises $25M to advance its artificial womb technology for premature babies.
Earlier, in 2020, the Center for Fetal Research in the Center for Fetal Diagnosis and Treatment at Children’s Hospital of Philadelphia continued its focus on developing a unique womb-like device that could reduce mortality and disability for extremely premature babies.
Market Trends- Technological developments in the field of the artificial womb
Following rapid progress in the development of full prototypes, preclinical and clinical trials are scheduled in the next few years, resulting in the strong market potential for the industry. The use of artificial placenta and environment to increase the survival and quality of life of extremely premature babies.
The technology used in artificial wombs to support late preterm fetuses is widely being researched for extending the technology for fetus development. The artificial womb represents an unprecedented potential for improvement in clinical outcomes in critically preterm infants.
Prematurity is a leading cause of infant morbidity and mortality, supporting strong demand for artificial wombs. Driven by advancements in neonatal intensive care, the artificial womb is likely to emerge as a substitute for the protective environment of the maternal womb.
Artificial Womb Market Segmentation
The artificial womb market is segmented across diverse end-use applications including Research Centers, Super-Specialty Hospitals, and Other End Users. Currently, several research institutes are focusing on developing artificial wombs for premature babies.
Leading research institutes and companies are focusing on offering a bridge between a natural womb and the outside world to support preterm babies with additional time for their respiratory system to develop completely.
Further, over the long-term future, the adoption of the artificial womb is likely to be widespread across super-specialty hospitals.
Artificial Womb Market Landscape
In December 2022, Ectolife announced its concept to launch a facility to grow around 30,000 babies yearly. According to the company, parents can choose the baby's level of intelligence, height, hair, eye color, physical strength, and skin tone. The company plans to run the facility on renewable energy and provides continuous access for monitoring to parents through advanced technologies.
Ethical concerns likely to delay the development of facilities
Research on developing human beings in labs is controversial, which can cause delays in undertaking preclinical and clinical trials. The ethical limit is often thirteen days, and amidst concerns ranging from abstract issues about complete ectogenesis to more immediate issues, the delay in the development of facilities for helping smaller babies to survive can act as a market deterrent.
Geographical Analysis
North America is likely to be the early adopter of the artificial womb, followed by European markets. Further, strong growth prospects for population growth also support rapid adoption. The report provides a comprehensive analysis and outlook of the market growth prospects in the US, Germany, France, the UK, Spain, Italy, Japan, and other countries.
1. Executive Summary
1.1 Introduction to Artificial Womb Markets
1.2 Artificial Womb Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Artificial Womb Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Artificial Womb Market Trends
3.2 Key Artificial Womb Market Growth Drivers
3.3 Key Artificial Womb Market Growth Restraints
4 Artificial Womb Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Artificial Womb Market Segmentation- Outlook by Application
5.1 Artificial Womb Market Share Analysis by Application, 2023
5.2 Research Institutes: Artificial Womb Market Outlook to 2030
5.3 Super Specialty Hospitals: Artificial Womb Market Outlook to 2030
7.4 Other Centers- Artificial Womb Market Outlook to 2030
6. North America Artificial Womb Market Outlook and Opportunities to 2030
6.1 Market Snapshot, 2023
6.2 North America Artificial Womb Market Growth Opportunities
6.3 North America Artificial Womb Market Outlook by Application
6.4 North America Artificial Womb Market Outlook by Country
6.5 United States Artificial Womb Market Outlook
6.6 Canada Artificial Womb Market Outlook
7. Europe Artificial Womb Market Outlook and Opportunities to 2030
7.1 Market Snapshot, 2023
7.2 Europe Artificial Womb Market Outlook by Application
7.3 Europe Artificial Womb Market Outlook by Country
7.4 Germany Artificial Womb Market Outlook
7.5 France Artificial Womb Market Outlook
7.6 United Kingdom Artificial Womb Market Outlook
7.7 Spain Artificial Womb Market Outlook
7.8 Italy Artificial Womb Market Outlook
7.9 Other Europe Artificial Womb Market Outlook
8. Asia Pacific Artificial Womb Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 Asia Pacific Artificial Womb Market Outlook by Application
8.3 Asia Pacific Artificial Womb Market Outlook by Country
8.4 China Artificial Womb Market Outlook
8.5 Japan Artificial Womb Market Outlook
8.6 India Artificial Womb Market Outlook
8.7 Other Asia Pacific Artificial Womb Market Outlook
9. Rest of World Artificial Womb Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 South and Central America Artificial Womb Market Growth Opportunities
9.3 South and Central America Artificial Womb Market Outlook by Application
9.4 Middle East and Africa Artificial Womb Market Outlook by Application
10. Profiles of major world Artificial Womb Companies
10.1 Ectolife
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
10.2 Vitara Biomedical
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
12. Appendix
12.1 Publisher’s Expertise
12.2 List of Tables and Charts
12.3 List of Exhibits
12.4 Legal Disclaimer
End-use applications
North American region is projected to dominate the global artificial womb market
EctoLife Artificial Womb Facility, which can incubate up to 30,000 babies a year was announced in December 2022. The company markets artificial wombs as safe and pain-free alternatives.
There few major companies leading the market are Ectolife, Vitara Biomedical, and more other.
The global Artificial womb market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.